Abstract: P947 EZETIMIBE/SIMVASTATIN (E/S) AND ATORVASTATIN (A) TREATMENT MODIFY APOB, LDL-C, AND NON-HDL-C CORRELATIONS IN METABOLIC SYNDROME (MS) PATIENTS AT MODERATELY HIGH RISK(MHR)/HIGH RISK(HR) FOR CHD

✍ Scribed by Ballantyne, C; Grundy, S; Hsueh, W; Parving, H; Robinson, J; Rosen, J; Lin, J; Lowe, R; Shah, A; Tershakovec, A

• Book ID: 122725380
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 194 KB
• Volume: 10
• Category: Article
• ISSN: 1567-5688
• DOI: 10.1016/S1567-5688(09)71068-2